BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4267911)

  • 1. [ENT clinical study of a new anti-inflammatory drug: Imotryl].
    Garcin M; Gola R
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1971 Mar; 20(3):547-8. PubMed ID: 4267911
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of imotryl in current medical practice].
    Doulat R; Sotto JJ; Bouvet P; Baron JP
    Lyon Med; 1969 Dec; 222(47):1301-3. PubMed ID: 5369365
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic experience in the use of Mebron tablet (DA-398) in otorhinolaryngologic field].
    Kono K; Sekine K
    Jibiinkoka; 1970 Sep; 42(9):711-3. PubMed ID: 5466086
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical study of the indications for the use of the new anti-inflammatory irrigating solution, Hexo-imotryl].
    Benoit P; Michelet FX; Benoit JP; Festal F
    Rev Odontostomatol Midi Fr; 1971; 29(1):56-63. PubMed ID: 5093086
    [No Abstract]   [Full Text] [Related]  

  • 5. [Further contributions on the therapeutic action of Febutol in ORL].
    Perrella F; Alinei D
    Minerva Otorinolaringol; 1968; 18(2):94-8. PubMed ID: 5741565
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of a new anti-inflammatory agent in the field of otorhinolaryngology].
    Roux O
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1975 Sep; 24(7):545-7. PubMed ID: 129512
    [No Abstract]   [Full Text] [Related]  

  • 7. [Contribution to the study of anti-inflammatory agents in the surgical, stomatologic and ENT sequelae].
    Toucas P
    Rev Fr Odontostomatol; 1966; 13(7):1218-30. PubMed ID: 5225240
    [No Abstract]   [Full Text] [Related]  

  • 8. [Esfar in an ENT department].
    Traissac L; Pasquet J
    Rev Laryngol Otol Rhinol (Bord); 1976; 97(3-4):177-9. PubMed ID: 1034331
    [No Abstract]   [Full Text] [Related]  

  • 9. [Benzydamine hydrochlorate (or imotryl) in angeiologic practice (its value as adjuvant in sclerotherapy of varices)].
    Bourde C
    Mars Med; 1969; 106(5):459-65. PubMed ID: 5351038
    [No Abstract]   [Full Text] [Related]  

  • 10. [Note on a new anti-inflammatory agent in otorhinolaryngology].
    Lacher G
    Rev Laryngol Otol Rhinol (Bord); 1968; 89(7):499-501. PubMed ID: 5715348
    [No Abstract]   [Full Text] [Related]  

  • 11. [Anti-inflammatory agents in ORL diseases. Introduction].
    Passali D; Marcucci L
    Acta Otorhinolaryngol Ital; 1990; 10 Suppl 28():5-9. PubMed ID: 2248027
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical study of the analgesic and anti-inflammatory activity of AF-864 (benzydamine hydrochloride) in otorhinolaryngology].
    Di Fede S
    Policlinico Prat; 1966 Nov; 73(46):1540-5. PubMed ID: 5998755
    [No Abstract]   [Full Text] [Related]  

  • 13. [To prevent the chronic pattern and complications of acute ENT inflammation].
    Pal'chun VT
    Vestn Otorinolaringol; 2009; (2):4-6. PubMed ID: 19530280
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of Elarzone-Dausse, a new E.N.T. anti-inflammatory agent].
    Ammar-Khodja A
    JFORL J Fr Otorhinolaryngol Audiophonol Chir Maxillofac; 1974 Sep; 23(7):665-6 passim. PubMed ID: 4280432
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical trial of an antibiotic and decongestant combination: proxibron].
    Haguenauer JP; Bouchayer M; Jacquemard C
    J Fr Otorhinolaryngol Audiophonol Chir Maxillofac (1967); 1969 Apr; 18(4):247-9. PubMed ID: 4249627
    [No Abstract]   [Full Text] [Related]  

  • 16. [Consensus conference on the rationale for use of anti-inflammatory agents in otorhinolaryngology].
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):5-40. PubMed ID: 15462021
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of a new antalgic anti-inflammatory agent in otorhinolaryngology].
    Portmann M; Pardes P
    Rev Laryngol Otol Rhinol (Bord); 1971; 92(3):235-8. PubMed ID: 5565287
    [No Abstract]   [Full Text] [Related]  

  • 18. [Manifestations of Wegener granulomatosis of the ENT area? Differential diagnosis, therapy?].
    Riemann R
    Laryngorhinootologie; 2003 Mar; 82(3):219. PubMed ID: 12710410
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical experimentation of LD 4644 in O.R.L].
    Decroix G; Desaulty A
    Lille Med; 1973 Nov; 18(9):1035-8. PubMed ID: 4603401
    [No Abstract]   [Full Text] [Related]  

  • 20. [Results and considerations in the use of an anti-inflammatory and analgesic preparation in otorhinolaryngology].
    Girardi G
    Minerva Med; 1967 Apr; 58(32):1487-9. PubMed ID: 6029515
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.